BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2101906)

  • 1. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
    Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
    Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS.
    Fischbein A; Sharma OK; Valciukas JA; Bekesi JG; Buschman F; Apell G; Kohn M; Boesch RR; Teirstein A; Selikoff IJ
    Cancer Detect Prev; 1985; 8(1-2):271-7. PubMed ID: 4064047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary nucleosides.
    Schram KH
    Mass Spectrom Rev; 1998; 17(3):131-251. PubMed ID: 10095827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters.
    Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK
    Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
    Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
    Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
    Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
    Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
    Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
    Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of whole-body RNA catabolism based on the urinary modified nucleoside levels of cancer and AIDS patients.
    Nakano K; Nakao T; Schram KH; Hammargren WM
    Nucleic Acids Symp Ser; 1991; (25):125-6. PubMed ID: 1726802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
    Seidel P; Seidel A; Herbarth O
    Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
    Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a monoclonal antibody to detect elevated levels of a modified nucleoside, N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, in the urine of breast cancer patients.
    Vold BS; Kraus LE; Rimer VG; Coombes RC
    Cancer Res; 1986 Jun; 46(6):3164-7. PubMed ID: 3698031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and identification of urinary nucleosides. Applications of high-performance liquid chromatographic methods to the synthesis of 5'-deoxyxanthosine and the simultaneous determination of 5,6-dihydrouridine and pseudouridine.
    Nakano K; Yasaka T; Schram KH; Reimer ML; McClure TD; Nakao T; Yamamoto H
    J Chromatogr; 1990 Aug; 515():537-46. PubMed ID: 2283377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients.
    Nakano K; Shindo K; Yasaka T; Yamamoto H
    J Chromatogr; 1985 Sep; 343(1):21-33. PubMed ID: 4066857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
    Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome.
    Borek E; Sharma OK; Buschman FL; Cohn DL; Penley KA; Judson FN; Dobozin BS; Horsburgh CR; Kirkpatrick CH
    Cancer Res; 1986 May; 46(5):2557-61. PubMed ID: 3008993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.